The ADA followed, stating that ‘adding metformin to insulin therapy may reduce insulin requirements and improve metabolic control in overweight/obese patients with poorly controlled type 1 diabetes’ [28]. The gene discussed is INS; the disease is type 1 diabetes mellitus.